On 20 February 2025, Mayne Pharma executed a SID for a recommended scheme of arrangement under which US company Cosette Pharmaceuticals Holdings Inc would acquire all the issued shares in Mayne Pharma ...
"We are very pleased to have received FIRB approval to both our acquisition of 100% of Global Uranium, and a 21.9% interest in Ubaryon. In addition, Urenco has received FIRB approval to make its ...
Should you have feedback on this article, please complete the fields below. Please indicate if your feedback is in the form of a letter to the editor that you wish to have published. If so, please be ...
Should you have feedback on this article, please complete the fields below. Please indicate if your feedback is in the form of a letter to the editor that you wish to have published. If so, please be ...
Oct 16 (Reuters) - An Australian court on Wednesday stopped U.S. drugmaker Cosette from abandoning its A$672 million ($437.6 million) takeover of Mayne Pharma (MYX.AX), opens new tab, which now awaits ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results